In the past 20 years chain pharmacies have done whatever they can to minimize any proactive laws advanced by the profession of pharmacy. Take mandatory counseling. I don't think I need to list examples of how corporate chains have underminded this law (one only need to pick up a new prescription at CVS). Because of fines that have been levied by the states board of pharmacy against chains for infraction of this law, employers have designed ways to shift the culpability from the chain to the pharmacist (ie., Rph acknowledgement of counseling at the point of sale via bar codes or touch pads, etc..) We can look at the change of ratio between pharmacists and technicians pushed through by the chain pharmacies (surely they didn't advocate this so as to help society receive their meds in a more timely manner). Regardless of the example, in light of such behavior I just don't see the chains endorsing the changes you've been advocating in the past couple of posts. Not that what you've advocated is wrong. I think everyone on this forum would love to see wide acceptance of your proposals. But in all fairness, when a pharmacist steps behind the counter at a Walgreens I seriously doubt he or she sees a KPI which measures MTM or the number of counsels on new prescriptions that have occurred. The point of my disagreement with your view regarding retail pharmacy is that your proposals (worthy as they may be) still have to through a CEO's board room first. Despite the chain's board room, if you were graduating today with over 120k of debt would your priority be advancing a proactive future for pharmacy and possibly incurring the ire of your employer or picking up as many extra hours as possible so as to pay off that debt?
As for the analogy, I am simply trying to point out that the state of the profession of pharmacy goes hand in hand with the state of pharmacists. Especially if we take into consideration that the majority of pharmacists (maybe 70%) work within retail. I'm sorry for any misconception.
You have not said anything new. Your points are:
1. Retail pharmacy will keep driving volume efficiency to increase profit.
2. 70% of pharmacists are retail.
3. Retail pharmacy will worsen?
4. MTM is unrealistic
Well, you do know there are 2 bills, 1 in senate and 1 in house to allow MTM reimbursement program under Medicare B to include pharmacist as a provider?
The "Outcomes" pilot currently pays $50 for comprehensive review and $20 per interventions such as duplicate therapy or brand to generic under Medicare B.
Perhaps you missed the thread on this topic.
If there's a profit to be made through MTM, do you really believe CEOs will turn it down? The difference between OBRA 90 and MTM? MTM gets paid...OBRA 90 doesn't.
I will give you another example:
Vaccination. Some pharmacists see it as extra work. Some see it as an opportunity. Chains forced pharmacists to provide vaccination...why? Reimbursement. Therefore, to say Chain CEO's vote against every change except for more volume is false. They want more profit. Pharmacy just needs to find synergistic program that drives more profit while enhancing pharmacy practice. And I firmly believe MTM is the key.
Once CMS reimburses MTM, other 3rd party payors will follow. That's the typical pattern.
Again, kids heavily strapped to student loans will suffer and the majority of pharmacists will reactively follow whatever is handed to them. But it will be the few trend setters who will shift and shape the future of pharmacy. You're either a follower or a leader. And you better hope your leader leads you the right way.